Facebook
Twitter
LinkedIn
Forward2022 Montana Hematology Conference: A practical approach to hematologic malignancies in the community practice
2022 Montana Hematology Conference: A practical approach to hematologic malignancies in the community practice features experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues. Participation in this conference will provide learners an opportunity to hear experts' perspectives on translation of emerging and practice changing data into novel treatment strategies, personalize care according to patient and tumor characteristics, proactively mitigate and manage treatment-related toxicities, and answer challenging patient care questions during case-based discussion sessions. The goal of this activity is to improve the knowledge and competence of hematology and oncology providers in evidence-based management of hematologic malignancies.
Target Audience
- Hematologists
- Hematology fellows
- Hematology nurses
- Hematology nurse practitioners
- Hematology physician assistants
- Hematology pharmacists
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Review practical management of common hematologic malignancies in the community practice
- Outline the novel BTK inhibitors, other targeted therapies and CAR T-cell therapies for the treatment of chronic lymphocytic leukemia
- Discuss the approved therapies for treatment of newly diagnosed multiple myeloma, and selection of appropriate treatment based on disease and patient related characteristics
- Explain the current approved therapies for myelofibrosis, novel emerging treatment options and management of anemia associated with myelofibrosis
Conference Chair: Srinivas Tantravahi, MBBS, MRCP
Times listed below are in Mountain Standard Time (MST).
Session 1: Lecture
Moderator: Srinivas Tantravahi, MBBS, MRCP
6:00 PM to 6:20 PM: Management of CLL: How I chose first- and second-line treatments? - Deborah Stephens, DO
6:20 PM to 6:40 PM: Multiple Myeloma: How I select first-line therapy for multiple myeloma - Douglas Sborov, MD, MS
6:40 PM to 7:00 PM: Management of Myelofibrosis in the community practice - Srinivas Tantravahi, MBBS, MRCP
7:00 PM to 7:15 PM: Q & A
Panel: Deborah Stephens, DO, Douglas Sborov, MD, MS, and Srinivas Tantravahi, MBBS, MRCP
Session 2: Case based discussion
Moderator: Chad Pedersen, MD
7:15 PM to 7:30 PM: Case 1: Multiple myeloma - Justin Thomas, MD
7:30PM to 7:45 PM: Case 2: CLL - Kristina Hool, MD
7:45PM to 8:00 PM: Q & A
8:00 PM: Adjourn and Dinner
Shannon Isakson, RN is the Binaytara Foundation Nurse State Liaison for the states of Wyoming and Montana.
Shannon has the following disclosures: Independent Contractor with Caris Life Sciences
Douglas Sborov, MD MS
Deborah Stephens, DO
Srinivas Tantravahi, MBBS; MRCP
Kristina Hool
Chad Pedersen, MD
Available Credit
- 2.00 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 2.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 2.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.00 Contact Hours.
All exhibit spaces at this meeting have sold out. Please call/email Tara if you have any questions.
Price
Physicians (non-industry) - Free
Non-physician HCP (non-industry) - Free
Industry representatives - Registration Closed
Due to space limitations, registration for this activity is closed for industry attendees. If you are a healthcare provider NOT employed by the industry, please email cme@binayfoundation.org to register.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
- No refunds will be issued if registration is cancelled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.